基质金属蛋白酶和肿瘤坏死因子-α产生的环状抑制剂的设计与合成。 - Suppr

Suppr

超能文献

Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-alpha production.

作者信息

Xue C B, He X, Roderick J, DeGrado W F, Cherney R J, Hardman K D, Nelson D J, Copeland R A, Jaffee B D, Decicco C P

机构信息

The DuPont Merck Pharmaceutical Company, Experimental Station, Wilmington, Delaware 19880-0500, USA.

出版信息

J Med Chem. 1998 May 21;41(11):1745-8. doi: 10.1021/jm970849z.

DOI:10.1021/jm970849z

PMID:9599225

Abstract

摘要

相似文献

Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-alpha production.基质金属蛋白酶和肿瘤坏死因子-α产生的环状抑制剂的设计与合成。

J Med Chem. 1998 May 21;41(11):1745-8. doi: 10.1021/jm970849z.

Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.基于磷酰胺的异羟肟酸作为基质金属蛋白酶抑制剂的设计与合成

J Med Chem. 1999 Jan 14;42(1):87-94. doi: 10.1021/jm980142s.

Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.一种（芳基磺酰基）异羟肟酸模板对磷酸二酯酶4和基质金属蛋白酶的双重抑制作用

J Med Chem. 1999 Feb 25;42(4):541-4. doi: 10.1021/jm980567e.

Discovery of potent, achiral matrix metalloproteinase inhibitors.强效非手性基质金属蛋白酶抑制剂的发现。

J Med Chem. 1998 Sep 10;41(19):3568-71. doi: 10.1021/jm980253r.

Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.γ-内酰胺异羟肟酸作为肿瘤坏死因子α转换酶选择性抑制剂的发现：设计、合成及构效关系

J Med Chem. 2002 Nov 7;45(23):4954-7. doi: 10.1021/jm0255670.

Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.基于结构设计并合成一系列在P1位带有季羟基的异羟肟酸作为基质金属蛋白酶抑制剂。

Bioorg Med Chem Lett. 1998 Apr 7;8(7):837-42. doi: 10.1016/s0960-894x(98)00125-5.

Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid derivatives as MMP inhibitors.亚氨基二乙酰单异羟肟酸衍生物作为基质金属蛋白酶抑制剂的设计、合成及分子模拟研究

Bioorg Med Chem. 2006 Nov 15;14(22):7539-50. doi: 10.1016/j.bmc.2006.07.011. Epub 2006 Jul 27.

A novel series of highly selective inhibitors of MMP-3.一系列新型的基质金属蛋白酶-3高选择性抑制剂。

Bioorg Med Chem Lett. 2007 Dec 15;17(24):6750-3. doi: 10.1016/j.bmcl.2007.10.042. Epub 2007 Oct 17.

Macrocyclic amino carboxylates as selective MMP-8 inhibitors.

J Med Chem. 1998 May 21;41(11):1749-51. doi: 10.1021/jm970850y.

3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.3-羟基-4-芳基磺酰基四氢吡喃基-3-异羟肟酸是基质金属蛋白酶-13和软骨聚集蛋白聚糖酶的新型抑制剂。

Bioorg Med Chem Lett. 2004 Sep 20;14(18):4727-30. doi: 10.1016/j.bmcl.2004.06.081.

引用本文的文献

Challenges in Matrix Metalloproteinases Inhibition.基质金属蛋白酶抑制的挑战。

Biomolecules. 2020 May 5;10(5):717. doi: 10.3390/biom10050717.

Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease.基于恶二唑的诺如病毒3CL蛋白酶细胞可渗透大环过渡态抑制剂

J Med Chem. 2016 Mar 10;59(5):1899-913. doi: 10.1021/acs.jmedchem.5b01464. Epub 2016 Feb 8.

The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo.RECK蛋白的Kazal基序可抑制MMP-9的分泌和活性，并在体外和体内降低肺癌细胞的转移能力。

J Cell Mol Med. 2008 Dec;12(6B):2781-9. doi: 10.1111/j.1582-4934.2008.00215.x. Epub 2008 Jan 11.

DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants.DPC 681和DPC 684：针对临床相关突变变体具有活性的强效、选择性人类免疫缺陷病毒蛋白酶抑制剂。

Antimicrob Agents Chemother. 2001 Nov;45(11):3021-8. doi: 10.1128/AAC.45.11.3021-3028.2001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验